kt 5823 has been researched along with 20-alpha-dihydroprogesterone in 1 studies
Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (20-alpha-dihydroprogesterone) | Trials (20-alpha-dihydroprogesterone) | Recent Studies (post-2010) (20-alpha-dihydroprogesterone) |
---|---|---|---|---|---|
317 | 0 | 59 | 534 | 4 | 26 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karpinski, E; Kline, LW | 1 |
1 other study(ies) available for kt 5823 and 20-alpha-dihydroprogesterone
Article | Year |
---|---|
Progesterone inhibits gallbladder motility through multiple signaling pathways.
Topics: 17-alpha-Hydroxyprogesterone; 20-alpha-Dihydroprogesterone; Animals; Boron Compounds; Calcium; Carbazoles; Carrier Proteins; Cholecystokinin; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Gallbladder; Gallbladder Emptying; Genistein; Guinea Pigs; In Vitro Techniques; Indoles; Isoquinolines; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nifedipine; Peptide Fragments; Progesterone; Protein Kinase Inhibitors; Signal Transduction; Strontium; Sulfonamides | 2005 |